During the past decade, Baylor College of Medicine, Scott Department of Urology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor College of Medicine, Scott Department of Urology" #1 sponsor was "Baylor College of Medicine" with 4 trials, followed by "Photocure" with 2 trials sponsored, "Endo Pharmaceuticals" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Threshold Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine, Scott Department of Urology" #1 collaborator was "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine, Scott Department of Urology" are "Bladder Cancer" (2 trials), "Prostatic Neoplasms" (2 trials), "Benign Prostatic Hyperplasia" (1 trials), "Bladder Dysfunction" (1 trials) and "Erectile Dysfunction" (1 trials). Many other conditions were trialed in "Baylor College of Medicine, Scott Department of Urology" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine, Scott Department of Urology" are "Drug" (4 trials), "Genetic" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AA4500" (1 trials), "Darifenacin" (1 trials), "Hexvix" (1 trials) and "IL-12 gene" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine, Scott Department of Urology" are 7 trials for "Male" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Baylor College of Medicine, Scott Department of Urology". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Baylor College of Medicine, Scott Department of Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine, Scott Department of Urology, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".